| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO | Director
2 companies
Traversa Sergio is a Chief Executive Officer at RLMD, with reported holdings spanning 2 companies. Recent filings cover 29 purchases and 24 sales. Those positions are worth an estimated $6.2M at current prices.
Our model assigns Traversa Sergio a middling insider score of 64/100, based on 18 past trades. Over a 12-month horizon, 53.8% of those trades were profitable, with an average 12-month return of +9.1%.
Traversa Sergio's largest disclosed position is in RLMD as Chief Executive Officer, worth about $6.1M. Net of sales, the recent Form 4 record there shows accumulation of 1,350,459 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 200,000 | $4.14 | $828,000.00 | +15.4% | - | - | |
| Dec 15, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 27,500 | $4.12 | $113,300.00 | +2.2% | +41.7% | - | |
| Nov 5, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 272,500 | $2.20 | $599,500.00 | +27.3% | +51.4% | - | |
| Aug 28, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 265,976 | $0.67 | $178,094.99 | +36.2% | +440.6% | +458.7% | |
| May 20, 2025 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 350,000 | $0.50 | $174,712.71 | +91.1% | +11.2% | +1101.0% | |
| Sep 11, 2024 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 140,000 | $2.82 | $395,114.52 | +57.4% | -84.4% | -49.7% | |
| Jan 31, 2024 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 100,000 | $3.87 | $386,737.56 | +69.4% | -7.4% | -91.0% | |
| Dec 8, 2022 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Buy | 55,250 | $2.10 | $115,804.00 | +62.2% | +51.6% | +18.0% | |
| Jul 1, 2022 | RLMD Relmada Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 29,767 | $18.80 | $559,577.24 | -25.1% | +97.8% | -86.6% | |
| Mar 10, 2021 | RLMD Relmada Therapeutics, Inc. | CEO | Sale+OE | 10,000 | $35.48 | $354,844.92 | -10.1% | -13.8% | -35.7% |